Table 2. The characteristics of the patients included in the study.
Sex | Female 100% | ||
Age | 26–97 | Average 55,67 | |
Grade | 1 | 13,6% | (n = 36) |
2 | 36,3% | (n = 96) | |
3 | 32,2% | (n = 85) | |
Nd | 17,8% | (n = 47) | |
Stage | IA | 1% | |
IB | 60% | ||
IIA | 20% | ||
IIB | 18% | ||
III | 1% | ||
Treatment | Radiotherapy (50 Gy) + brachytherapy (15 Gy) + cisplatin (6 cycles: 40 mg/m2) |